Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Physostigmine Salicylate

Catalog No. T0130 Copy Product Info
Purity: 99.95%
😃Good
Physostigmine, a parasympathomimetic alkaloid, is a reversible cholinesterase inhibitor. It extracts from the Calabar bean.

Physostigmine Salicylate

Copy Product Info
😃Good
Catalog No. T0130

Physostigmine, a parasympathomimetic alkaloid, is a reversible cholinesterase inhibitor. It extracts from the Calabar bean.

Physostigmine Salicylate
Cas No. 57-64-7
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$33In StockIn Stock
5 mg$75In StockIn Stock
10 mg$98In StockIn Stock
25 mg$155In StockIn Stock
50 mg$196In StockIn Stock
1 mL x 10 mM (in DMSO)$82In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.95%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Physostigmine Salicylate AI Summary
Physostigmine Salicylate exhibits strong bioactivity and potent inhibition properties across multiple targets. It inhibits human erythrocyte Acetylcholinesterase (AChE) with an IC50 value of 28.0 nM and human plasma Butyrylcholinesterase (BChE) with an IC50 value of 16.0 nM, showing a moderate selectivity value of 2.0. Additionally, it inhibits Torpedo california AChE with an IC50 of 21.3 nM, displaying concentration-dependent inhibition ranging from 24.71% to 64.3% at different concentrations (7.56 nM to 30.3 nM). The compound also demonstrates reversible mixed-type inhibition of electric eel acetylcholinesterase with a Ki value of 210.0 nM. Beyond cholinesterase inhibition, Physostigmine Salicylate shows various bioactivities, including: 1. Potent inhibition of Human Jumonji Domain Containing 2E (JMJD2E). 2. Enhancement of SMN2 splice variant expression. 3. Agonistic and antagonistic properties on the Hypoxia Response Element Signaling Pathway. 4. Inhibition of Aldehyde Dehydrogenase 1 (ALDH1A1) and 15-Hydroxyprostaglandin Dehydrogenase (HPGD). 5. Inhibition of Chronic Active B-Cell Receptor Signaling and the malarial parasite plastid with delayed death activity. 6. Substrate-like properties for Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1). 7. Inducing DNA re-replication in MCF 10a normal breast cells and inhibiting Glutaminase (GLS). 8. Inducing synthetic lethality in tumor cells producing 2HG, specifically in the HT-1080-NT fibrosarcoma cell line. Furthermore, Physostigmine Salicylate inhibits sodium fluorescein uptake in both OATP1B1 and OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 µM, with inhibition percentages of 115.97% and 110.77%, respectively, suggesting a high affinity for these transporters..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Physostigmine, a parasympathomimetic alkaloid, is a reversible cholinesterase inhibitor. It extracts from the Calabar bean.
Chemical Properties
Molecular Weight413.48
FormulaC22H27N3O5
Cas No.57-64-7
SmilesOC(=O)c1ccccc1O.[H][C@]12N(C)CC[C@@]1(C)c1cc(OC(=O)NC)ccc1N2C
Relative Density.no data available
Storage & Solubility Information
StorageStore at low temperature | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 125 mg/mL (302.31 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.84 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4185 mL12.0925 mL24.1850 mL120.9248 mL
5 mM0.4837 mL2.4185 mL4.8370 mL24.1850 mL
10 mM0.2418 mL1.2092 mL2.4185 mL12.0925 mL
20 mM0.1209 mL0.6046 mL1.2092 mL6.0462 mL
50 mM0.0484 mL0.2418 mL0.4837 mL2.4185 mL
100 mM0.0242 mL0.1209 mL0.2418 mL1.2092 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Physostigmine Salicylate | purchase Physostigmine Salicylate | Physostigmine Salicylate cost | order Physostigmine Salicylate | Physostigmine Salicylate chemical structure | Physostigmine Salicylate formula | Physostigmine Salicylate molecular weight